Evidence map›Paper›PMID 1323530›Full record

ArticleInflammation1992

Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.

M S Bajaj, R R Kew, R O Webster, T M Hyers

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Clonal monocytosis of renal significance.Kidney international · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Neutrophil phenotypes in health and disease.European journal of clinical investigation · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M S BajajDepartment of Internal Medicine, St. Louis University School of Medicine, Missouri 63110.
R R Kew
R O Webster
T M Hyers

Funding

ROLE OF COMPLEMENT AND INFLAMMATORY CELLS IN LUNG INJURYK04HL001542 · NHLBI · SAINT LOUIS UNIVERSITY · PI WEBSTER, ROBERT O. · 1985 to 1989
–
SCOR IN ADULT RESPIRATORY FAILUREP50HL030572 · NHLBI · SAINT LOUIS UNIVERSITY · PI HYERS, THOMAS M. · 1985 to 1993
–
MULTIDISCIPLINARY LUNG DISEASE RESEARCH TRAINING PROGRAMT32HL007050 · NHLBI · SAINT LOUIS UNIVERSITY · PI LONGMORE, WILLIAM J · 1985 to 1995
–
NHLBI NIH HHS HL-01542NHLBI NIH HHS HL-07050NHLBI NIH HHS HL-30572
6 · The paper itself

Abstract

Recombinant human tumor necrosis factor-alpha (rTNF) stimulated increased generation of superoxide anion (O2-) by human neutrophils in a concentration-dependent fashion. Preincubation of human neutrophils with rTNF (2.2-2200 units/ml) for 10 min enhanced the subsequent generation of O2- in response to C5a and f-Met-Leu-Phe (FMLP). Recombinant TNF did not enhance O2- generation by neutrophils stimulated with phorbol myristate acetate (PMA). Recombinant TNF alone failed to induce release of myeloperoxidase (MPO) and lysozyme by neutrophils. However, it did enhance the release of MPO and lysozyme by neutrophils stimulated with C5a and FMLP, but not with PMA. Although rTNF alone (0.001-50,000 units/ml) was not chemotactic for neutrophils, preincubation of neutrophils with rTNF (0.001-0.1 units/ml) enhanced the chemotactic activity of suboptimal concentrations of C5a (0.1 nM) and FMLP (5 nM). Neutrophils treated with high concentrations of rTNF (100-10,000 units/ml) showed inhibition of random movement and of chemotaxis induced by C5a or FMLP. We conclude from these studies that rTNF primes neutrophils for enhanced responses to subsequent stimuli and thus may augment the inflammatory response by increased oxidant production and lysosomal enzyme release and promote down-regulation of chemotactic movement.

Indexed as

Chemotaxis, LeukocyteComplement C5aCytoplasmic GranulesDrug SynergismHumansMuramidaseNeutrophilsN-Formylmethionine Leucyl-PhenylalanineOxygenPeroxidaseRecombinant ProteinsRespiratory BurstSuperoxidesTumor Necrosis Factor-alphaComplement C5aMuramidaseN-Formylmethionine Leucyl-PhenylalanineOxygenPeroxidaseRecombinant ProteinsSuperoxidesTumor Necrosis Factor-alpha

Identifiers

PMID1323530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.